Compare RCKT & OOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCKT | OOMA |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | United States | United States |
| Employees | N/A | 1186 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.9M | 343.1M |
| IPO Year | N/A | 2015 |
| Metric | RCKT | OOMA |
|---|---|---|
| Price | $3.53 | $11.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 3 |
| Target Price | ★ $29.12 | $19.00 |
| AVG Volume (30 Days) | ★ 2.0M | 199.3K |
| Earning Date | 11-06-2025 | 12-08-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $264,115,000.00 |
| Revenue This Year | N/A | $6.45 |
| Revenue Next Year | N/A | $11.53 |
| P/E Ratio | ★ N/A | $129.93 |
| Revenue Growth | N/A | ★ 4.22 |
| 52 Week Low | $2.19 | $9.79 |
| 52 Week High | $15.00 | $15.71 |
| Indicator | RCKT | OOMA |
|---|---|---|
| Relative Strength Index (RSI) | 56.59 | 50.22 |
| Support Level | $3.30 | $10.50 |
| Resistance Level | $3.45 | $12.80 |
| Average True Range (ATR) | 0.20 | 0.61 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 90.51 | 52.95 |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.